Stiefel Sues Cobrek, Perrigo Over Generic Acne Drug
Law360 (March 13, 2009, 12:00 AM EDT) -- Stiefel Laboratories Inc. has sued Cobrek Pharmaceuticals Inc. and its partner Perrigo Co. over their plans to develop a generic version of the acne treatment Evoclin, which Stiefel claims would infringe...
To view the full article, register now.
Try Law360 FREE for seven days
Already a subscriber? Click here to login
